Original Source(s)
Related Content
Phoenix Children’s Joins First Controlled Clinical Trial of Genetic Therapy for Dravet Syndrome
The first controlled phase 3 trial of a genetic therapy for Dravet syndrome is now underway – with Phoenix Children's as one of 28 sites nationwide.
HHS Ends Federal Medicaid and CHIP Funding for Sex-Rejecting Procedures for Children and Youth
August 11, 2026
SCPC Care: Non-Age-Related Factors Contribute to Timing
A literature review published in Future Cardiology suggests that providers should look beyond chronological age to various modifiable physiologic factors when planning a superior cavopulmonary connection (SCPC) procedure.